Publikationen pro Jahr
Publikationen pro Jahr
Fingerprint
Ergründen Sie die Forschungsthemen, in denen Sarah Hochmann aktiv ist. Diese Themenbezeichnungen stammen aus den Werken dieser Person. Zusammen bilden sie einen einzigartigen Fingerprint.
- 1 Ähnliche Profile
-
Human Cardiac Microtissues Display Improved Engraftment and Survival in a Porcine Model of Myocardial Infarction
Demkes, E., Cervera-Barea, A., Ebner-Peking, P. (Co-Autor/-in), Wolf, M. (Co-Autor/-in), Hochmann, S. (Co-Autor/-in), Scheren, A. S., Bijsterveld, M., van Oostveen, C. M., Jansen, M., Visser, J., Triebert, W., Halloin, C., Dobbe, J. G. G., de Vos, J., Schürz, M., Danmayr, J., Aalders, M. C. G., Boink, G. J. J., Neef, K. & Strunk, D. (Co-Autor/-in) &3 mehr, , 13 März 2025, in: Journal of Cardiovascular Translational Research. 2025, 17 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
Open Access -
Spexin expression in the human bile duct and perihilar cholangiocarcinoma
Huber, S. (Erstautor/-in), Fitzner, T., Feichtinger, R. G. (Co-Autor/-in), Kraus, T. (Co-Autor/-in), Gaisbauer, S. (Co-Autor/-in), Hochmann, S. (Co-Autor/-in), Sotlar, K. (Co-Autor/-in), Kofler, B. (Co-Autor/-in) & Varga, M. (Letztautor/-in), Juni 2025, in: PEPTIDES . 188, 8 S., 171405.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
Open Access -
BEATS - MIGRANE: Biomarker Etablishment of Activated Targets in Skin for Migrane
Zwicklhuber, J., Hochmann, S. (Co-Autor/-in), Stefani, A. (Co-Autor/-in), Wolf, M. (Co-Autor/-in), Poupardin, R. (Co-Autor/-in), Maeding, N. (Co-Autor/-in), Leis, S. (Co-Autor/-in), Weber, D. (Co-Autor/-in), Tevini, J. (Co-Autor/-in), Kofler, B. (Co-Autor/-in), Russe, E. (Co-Autor/-in) & Strunk, D. (Co-Autor/-in), 28 Juni 2024, (Eingereicht).Publikation: Konferenzbeitrag › Poster › Begutachtung
-
Lack of Effect of Platelet- and Stromal Cell-derived EVs on Inflammation-induced 3D Chondrogenesis
Morávek, M., Wolf, M. (Co-Autor/-in), Hochmann, S. (Co-Autor/-in), Maeding, N. (Co-Autor/-in), Lopes Pedroso, L. (Co-Autor/-in), Stefani, A. (Co-Autor/-in), Zwicklhuber, J. (Co-Autor/-in), Raninger, A. (Co-Autor/-in), Schallmoser, K. (Co-Autor/-in) & Strunk, D. (Co-Autor/-in), 16 Sept. 2024.Publikation: Konferenzbeitrag › Poster › Begutachtung
-
A protein corona around human platelet-derived EVs promotes regenerative functions
Schallmoser, K., Gueths Gomes, F., Cronemberger Andrade, A., Wolf, M., Hochmann, S., Krisch, L., Maeding, N., Regl, C., Poupardin, R., Ebner-Peking, P., Huber, C., Meissner-Kober, N. & Strunk, D., 2023.Publikation: Konferenzbeitrag › Abstrakt
-
Establishment of biomarkers for migraine in the skin: A special focus on thermoreceptors
Russe, E. (Leitende(r) Forscher/-in), Leis, S. (CoPI), Hochmann, S. (CoPI), Weber, D. (CoPI) & Rinnerthaler , M. (CoPI)
1/04/24 → 31/03/27
Projekt: Forschung
-
scarRNA: mRNA-based therapeutics for the Treatment of atrophic scars
Strunk, D. (Leitende(r) Forscher/-in), Mittermeir, M. (Weitere Forschende) & Hochmann, S. (Weitere Forschende)
1/08/17 → 1/09/18
Projekt: Forschung
-
3D-chondrogenesis in vitro
Hochmann, S. (Gastredner/in)
2017Aktivität: Gespräch oder Vortrag › Vortrag
-
Endogenous mRNA is used to translate genetic information into functional proteins. Together with our collaboration partner ACCANIS we use in vitro transcribed (IVT), exogenously administered RNA that mimics natural mRNA, with modifications that improve its stability and translatability. Towards developing new RNA-based Therapies we are currently validating various therapeutic targets in skin explant cultures and different stem cell models
Hochmann, S. (Kooperation)
2016Aktivität: Sonstige wissenschaftliche Aktivitäten › Kooperation
-
Regeneration of injured tissues requires effective therapeutic strategies supporting vasculogenesis. The lack of instantly available autologous cell sources and immunogenicity of allogeneic endothelial (progenitor) cells limits clinical progress. Based on the immunosuppressive potency of mesenchymal stem/progenitor cells (MSCs), we investigated whether crosstalk between endothelial colony-forming progenitor cells (ECFCs) and MSCs during vasculogenesis could lower allogeneic T cell responses against ECFCs allowing long-term engraftment in vivo. Crosstalk between UC-derived ECFCs and MSCs after combined transplantation can lower the risk of ECFC rejection, thus enabling their coapplication for therapeutic vasculogenesis. Stem Cells 2017;35:1233-1245.
Hochmann, S. (Kooperation)
2010Aktivität: Sonstige wissenschaftliche Aktivitäten › Kooperation